• Publications
  • Influence
Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study
Aliment Pharmacol Ther 2010; 32: 377–383
  • 319
  • 19
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe. The reasons for these changes remain unknown. The aim of this study was to investigate whether anExpand
  • 281
  • 16
  • PDF
The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
BACKGROUND AND OBJECTIVES In this study the impact of gender, age, type of M-component and concentration of immunoglobulins on the risk of malignant transformation in monoclonal gammopathy ofExpand
  • 57
  • 6
  • PDF
Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
BACKGROUND The liver produces and secretes bile acids into the small intestine. In the small intestine, most of the bile acids are absorbed in the distal ileum with portal vein transportation back toExpand
  • 46
  • 5
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
Background and aims Leucocyte migration to gut mucosa, mediated by integrin binding to mucosal addressin cell adhesion molecule (MAdCAM), is a promising target for therapeutic intervention inExpand
  • 119
  • 4
  • PDF
1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.
BACKGROUND AND AIM In Crohn's disease (CD), epidemiological data and animal studies suggest that vitamin D (vitD) has protective immune-modulating properties. 1,25-dihydroxyvitamin D3 andExpand
  • 71
  • 4
Fatigue in out‐patients with inflammatory bowel disease is common and multifactorial
Aliment Pharmacol Ther 2012; 35: 133–141
  • 68
  • 4
Drug‐specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
Aims Intravenous (IV) iron infusions have been associated with hypophosphataemia (HP) and hypersensitivity reactions (HSRs). No studies have compared the side effects of ferric carboxymaltose (FCM)Expand
  • 38
  • 4
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
These national clinical guidelines outlining the screening, prophylaxis and critical information required prior to initiating anti-TNF-alpha treatment have been approved by the Danish Society forExpand
  • 61
  • 4
Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL‐6 production and proliferation
Aliment Pharmacol Ther 2010; 32: 1364–1372
  • 37
  • 4